SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2190892

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2190892

Veterinary Chemistry Analyzer Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Veterinary Chemistry Analyzer Market reached USD 2.04 billion in 2025 and is projected to grow at a 9.4% CAGR from 2026 to 2035. The market is expected to cross USD 5 billion valuation by 2035. Instruments, reagents, and consumables support testing of blood, urine, and plasma in companion and production animals. More practices conduct routine chemistry during visits, increasing the usefulness of installed equipment. Recurring panels, cartridges, and strips support demand between hardware replacements, connecting commercial performance with testing intensity and the clinical functions available on each platform.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$2.04 Billion
Forecast Value$5 Billion
CAGR9.4%

Companion-animal care, expanded test menus, and portable connectivity drive growth. Wellness checks, anesthesia assessment, and chronic monitoring increasingly form coordinated clinical workflows, creating repeated test opportunities. Adding cardiac, endocrine, renal, and related capabilities can expand existing instrument use without another capital purchase. This increases the importance of suitable panels, cartridge availability, practice integration, and species-specific references. Compact connected systems also reach mobile veterinarians, rural clinics, mixed practices, and developing facilities where reference-laboratory turnaround is impractical. New placements can initiate continuing proprietary consumable purchases when supply and support remain dependable, linking broader access with recurring diagnostics rather than isolated equipment acquisition or one-time sample analysis.

Within type, benchtop chemistry analyzers accounted for 62% of revenue in 2025. Throughput, extensive menus, information integration, and confidence associated with established laboratory and hospital workflows support their position. Practices and facilities need equipment suited to their clinical volume and diagnostic requirements, making those capabilities commercially relevant. Suppliers can serve environments where routine and more comprehensive testing are managed within established operations. The category's role therefore reflects both analytical capacity and the workflow infrastructure around it. Customers evaluate how instruments support testing and result management, connecting benchtop equipment with dependable clinical processes whose performance depends on appropriate menus and integration rather than hardware specifications alone.

By product, instruments accounted for 28% of revenue in 2025. Placements create the installed base that supports later consumable use, making hardware important to the overall operating model. Purchasing increasingly considers lifetime reagent economics alongside the initial device. Suppliers need platforms that clinics can use repeatedly for useful tests and maintain through dependable materials. The category's commercial significance therefore extends beyond revenue at installation. Instrument access establishes diagnostic capability, while continuing use depends on menu relevance and operating affordability. Buyers can assess those requirements together, linking hardware choice with the subsequent costs and clinical value of running chemistry tests across routine appointments and longer-term monitoring needs.

The North America veterinary chemistry analyzer market generated USD 1.06 billion in 2025. Established companion-animal care, intensive testing, and substantial installed equipment create a mature commercial environment. Growth increasingly depends on menu additions and consumable use rather than first placements alone. U.S. corporate and independent practices support extensive wellness panels, while affordability and rural gaps influence investment outside substantial-volume sites. Suppliers need products and service suited to those differing settings. Regional opportunities therefore combine an established base with selective expansion, connecting continued use of deployed systems with the ability to broaden clinical value and maintain dependable reagent supply within practical veterinary practice budgets and workflows.

IDEXX Laboratories held over 59.0% market share in 2025. Catalyst, VetLab consumable relationships, and menu development underpin its position. Adding tests can raise use across existing installations without forcing a hardware replacement, strengthening the ongoing relationship with practices. Its commercial role consequently connects platform presence with recurrent materials and clinical usefulness. Customers need validated menus, reliable supply, and integration into everyday work, making those capabilities relevant to retention. IDEXX's position reflects the ability to serve continuing diagnostic requirements through established systems while expanding what practices can assess, linking analytical functions with repeated visits and the workflow arrangements used to manage companion-animal care.

Some of the major players in this market are Zoetis, Heska Corporation, Bioevopeak, Chengdu Seamaty Technology, DiaSys Diagnostic Systems, Eurolyser Diagnostica, HORIBA Medical, Randox Laboratories, Shenzhen Mindray Animal Medical Technology, SKYLA, and URIT Medical Electronic. Point-of-care portfolios, digital interpretation, broader clinical networks, and value-focused systems support different positions. Emerging and portable categories create opportunities, but expansion depends on validated consumables, distribution, technical service, and customer confidence. Platform integration and dependable reagent availability increasingly influence selection alongside instrument performance as practices seek repeatable diagnostic workflows.

Product Code: 3806

Table of Contents

Chapter 1. Research Methodology

  • 1.1 Research approach
  • 1.2 Quality Commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research Trail & Confidence Scoring
    • 1.3.1 Research Trail Components
    • 1.3.2 Scoring Components
  • 1.4 Data Collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2. Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Type trends
    • 2.2.2 Product trends
    • 2.2.3 Animal type trends
    • 2.2.4 Application trends
    • 2.2.5 End use trends
    • 2.2.6 Regional trends
  • 2.3 TAM analysis, 2027-2035
  • 2.4 CXO perspectives: strategic imperatives

Chapter 3. Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Cost structure
    • 3.1.4 Value addition at each stage
    • 3.1.5 Factor affecting the value chain
    • 3.1.6 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising pet adoption and increasing veterinary healthcare expenditure
      • 3.2.1.2 Technological advancements leading to improved diagnostic accuracy and automation
      • 3.2.1.3 Increasing prevalence of animal diseases and zoonotic infections
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with veterinary chemistry analyzers
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Pricing Analysis (Driven by Primary Research)
    • 3.4.1 Historical Price Trend Analysis
    • 3.4.2 Pricing Strategy by Player Type (Premium / Value / Cost-plus)
  • 3.5 Regulatory landscape
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia-Pacific
    • 3.5.4 Latin America
    • 3.5.5 Middle East and Africa
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Trade Data Analysis (Based on Paid Database)
    • 3.8.1 Import/Export Volume & Value Trends
    • 3.8.2 Key Trade Corridors & Tariff Impact
  • 3.9 Impact of AI & Generative AI on the Market (Driven by Primary Research)
    • 3.9.1 AI-Driven Disruption of Existing Business Models
    • 3.9.2 GenAI Use Cases & Adoption Roadmap by Segment
    • 3.9.3 Risks, Limitations & Regulatory Considerations
  • 3.10 Patent / IP Landscape
  • 3.11 Veterinary Healthcare Infrastructure Landscape
  • 3.12 Animal Disease Epidemiology & Disease Burden

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By Region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia-Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East and Africa
    • 4.2.2 Market Concentration Analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Key developments
    • 4.5.1 Mergers & acquisitions
    • 4.5.2 Partnerships & collaborations
    • 4.5.3 New product launches
    • 4.5.4 Expansion plans and funding
  • 4.6 Company tier benchmarking
    • 4.6.1 Tier classification criteria & qualifying thresholds
    • 4.6.2 Tier positioning matrix by revenue, geography & innovation

Chapter 5. Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Portable
  • 5.3 Benchtop

Chapter 6. Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Instruments
    • 6.2.1 Chemistry analyzers
    • 6.2.2 Urine analyzers
    • 6.2.3 Glucometers
    • 6.2.4 Blood gas and electrolyte analyzers
  • 6.3 Consumables
    • 6.3.1 Panels
      • 6.3.1.1 Preloaded multiple reagent panels
      • 6.3.1.2 Preloaded single-slide reagent panels
    • 6.3.2 Test strips
    • 6.3.3 Reagents

Chapter 7. Market Estimates and Forecast, By Animal Type, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Companion animals
    • 7.2.1 Dogs
    • 7.2.2 Cats
    • 7.2.3 Horses
    • 7.2.4 Other companion animals
  • 7.3 Livestock animals
    • 7.3.1 Cattle
    • 7.3.2 Pigs
    • 7.3.3 Sheep and goats
    • 7.3.4 Poultry

Chapter 8. Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Blood chemistry analysis
  • 8.3 Urinalysis
  • 8.4 Blood gas and electrolyte analysis
  • 8.5 Glucose monitoring
  • 8.6 Other applications

Chapter 9. Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 Veterinary laboratories
  • 9.3 Veterinary hospitals and clinics
  • 9.4 Other end use

Chapter 10. Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11. Company Profiles

  • 11.1 Bioevopeak
  • 11.2 Chengdu Seamaty Technology
  • 11.3 DiaSys Diagnostic Systems
  • 11.4 Eurolyser Diagnostica (Affiliate of Mars)
  • 11.5 Heska Corporation
  • 11.6 HORIBA Medical
  • 11.7 IDEXX Laboratories
  • 11.8 Randox Laboratories
  • 11.9 Shenzhen Mindray Animal Medical Technology
  • 11.10 SKYLA
  • 11.11 URIT Medical Electronic
  • 11.12 Zoetis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!